1. Market Research
  2. > Cancer Industry

Bladder Cancer Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Immunotherapy, Interventional Cardiology Device, Lung Cancer, Lymphoma, Oncology, Ovarian Cancer, Pancreatic Cancer, Point Of Care Testing, Prostate Cancer.


 
1-10 of 55 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

  • $ 1 100
  • Industry report
  • September 2016
  • by Igate Research

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new class of diagnostic tests that identify molecular and genetic ...

Global Bladder Cancer Partnering 2010 to 2016

Global Bladder Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Bladder Cancer: Analytical Tool

Bladder Cancer: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Target Atlas in Bladder Cancer: A Competitive Outlook

Target Atlas in Bladder Cancer: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Bladder Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in bladde ...

Bladder Cancer Drug Pathway Analyzer

Bladder Cancer Drug Pathway Analyzer

  • $ 1 794
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 141 targeted molecular therapies known to affect more than 219 specific intracellular signaling pathways ...

Bladder Cancer Drug Pipeline Update

Bladder Cancer Drug Pipeline Update

  • $ 1 794
  • Company report
  • August 2016
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development ...

North America Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

North America Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

About 2 500 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Chemotherapy Market in the US

  • June 2015
    256 pages
  • Therapy  

    Chemotherapy  

    Oncology  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.